Alterity Therapeutics (ATHE) Free Cash Flow (2016 - 2020)
Alterity Therapeutics' quarterly Free Cash Flow came in at -$6.2 million in Q2 2020, up 36.76% year-on-year from -$4.5 million in Q3 2019, and down 250.94% quarter-over-quarter from -$1.8 million in Q4 2019.
Alterity Therapeutics has reported Free Cash Flow for 5 years, with the latest figure at -$6.2 million in Q2 2020.
- For the quarter ending Q2 2020, Free Cash Flow rose 36.76% year-over-year to -$6.2 million; the trailing twelve-month figure through Dec 2021 stood at -$6.2 million (up 65.11% YoY), and the FY2025 full-year result was -$7.3 million, up 11.76% from the prior year.
- Free Cash Flow for Q2 2020 stood at -$6.2 million, down from -$1.8 million in the prior quarter.
- The five-year high for Free Cash Flow was -$47278.4 in Q2 2018, with the low at -$9.8 million in Q2 2019.
- Average Free Cash Flow over 5 years is -$3.8 million, with a median of -$4.4 million recorded in 2017.
- Year-over-year, Free Cash Flow soared 98.93% in 2018 and plunged 20575.33% in 2019.
- Tracing ATHE's Free Cash Flow over 5 years: stood at -$449190.3 in 2016, then tumbled by 100.19% to -$899256.0 in 2017, then slumped by 475.87% to -$5.2 million in 2018, then soared by 65.99% to -$1.8 million in 2019, then tumbled by 250.94% to -$6.2 million in 2020.
- The last three Free Cash Flow figures came in at -$6.2 million (Q2 2020), -$1.8 million (Q4 2019), and -$9.8 million (Q2 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -354.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -6.18 Mn |
| Jun 30, 2020 | -6.18 Mn |
| Dec 31, 2019 | -1.76 Mn |
| Dec 31, 2019 | -1.76 Mn |
| Jun 30, 2019 | -9.77 Mn |
| Jun 30, 2019 | -9.77 Mn |
| Dec 31, 2018 | -5.18 Mn |
| Dec 31, 2018 | -5.18 Mn |
| Jun 30, 2018 | -47,278.38 |
| Jun 30, 2018 | -47,278.38 |
| Dec 31, 2017 | -899,256.01 |
| Dec 31, 2017 | -899,256.01 |
| Jun 30, 2017 | -4.41 Mn |
| Jun 30, 2017 | -4.41 Mn |
| Dec 31, 2016 | -449,190.35 |
| Dec 31, 2016 | -449,190.35 |
| Jun 30, 2016 | -5.54 Mn |
| Jun 30, 2016 | -5.54 Mn |